Literature DB >> 15995795

Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

Blanca Ramírez-Ruiz1, María José Martí, Eduardo Tolosa, David Bartrés-Faz, Chistopher Summerfield, Pilar Salgado-Pineda, Beatriz Gómez-Ansón, Carme Junqué.   

Abstract

OBJECTIVE: To investigate the pattern of brain atrophy across time in a sample of Parkinson's disease (PD) patients with and without dementia using voxelbased morphometry (VBM) analysis.
METHODS: The initial sample comprised thirteen non-demented PD patients and sixteen demented patients. Longitudinal cognitive assessment and structural MRI were performed. The mean follow-up period was 25 months (SD=5.2). From this initial group, eight PD patients with dementia (5 men and 3 women) and eleven PD patients without dementia (7 men and 4 women) were reevaluated. MRI 3D structural images were acquired and analyzed by means of the optimized VBM procedure with Statistical Parametric Mapping (SPM2).
RESULTS: VBM analysis showed a progressive grey matter volume decrease in patients with PD without dementia in limbic, paralimbic and neocortical associative temporooccipital regions. In patients with dementia the loss mainly involved neocortical regions.
CONCLUSION: VBM revealed a significant loss of grey matter volume in PD patients with and without dementia with disease progression. The decrease in limbic and paralimbic regions is widespread in non-demented patients. Neocortical volume reduction is the most relevant finding in patients with dementia. This suggests that the neocortex is a substrate for dementia in Parkinson disease.

Entities:  

Mesh:

Year:  2005        PMID: 15995795     DOI: 10.1007/s00415-005-0864-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain.

Authors:  Susan M Resnick; Dzung L Pham; Michael A Kraut; Alan B Zonderman; Christos Davatzikos
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

3.  Cortical Lewy body disease.

Authors:  D J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

4.  Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.

Authors:  M T Hu; S J White; K R Chaudhuri; R G Morris; G M Bydder; D J Brooks
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

5.  Measuring the progression of idiopathic Parkinson's disease with [123I] beta-CIT SPECT.

Authors:  W Staffen; A Mair; J Unterrainer; E Trinka; G Ladurner
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

6.  Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

Authors:  P M Mattila; J O Rinne; H Helenius; D W Dickson; M Röyttä
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

7.  Longitudinal outcome of Parkinson's disease patients with psychosis.

Authors:  S A Factor; P J Feustel; J H Friedman; C L Comella; C G Goetz; R Kurlan; M Parsa; R Pfeiffer
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

8.  The locus ceruleus and dementia in Parkinson's disease.

Authors:  R M Zweig; J E Cardillo; M Cohen; S Giere; J C Hedreen
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

9.  Combined effect of age and severity on the risk of dementia in Parkinson's disease.

Authors:  Gilberto Levy; Nicole Schupf; Ming-Xin Tang; Lucien J Cote; Elan D Louis; Helen Mejia; Yaakov Stern; Karen Marder
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

10.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

View more
  40 in total

1.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

Review 2.  Neuroimaging and cognition in Parkinson's disease dementia.

Authors:  Lisa C Silbert; Jeffrey Kaye
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

3.  Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.

Authors:  Jing Zhang; Yun-Ting Zhang; Wei-Dong Hu; Li Li; Guang-Yao Liu; Yu-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Morphological differences in Parkinson's disease with and without rest tremor.

Authors:  David H Benninger; Sebastian Thees; Spyros S Kollias; Claudio L Bassetti; Daniel Waldvogel
Journal:  J Neurol       Date:  2009-02-04       Impact factor: 4.849

5.  Longitudinal white matter microstructural change in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher
Journal:  Hum Brain Mapp       Date:  2018-06-27       Impact factor: 5.038

6.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

7.  Whole-brain proton MR spectroscopic imaging in Parkinson's disease.

Authors:  Bonnie E Levin; Heather L Katzen; Andrew Maudsley; Judith Post; Connie Myerson; Varan Govind; Fatta Nahab; Blake Scanlon; Aaron Mittel
Journal:  J Neuroimaging       Date:  2012-12-10       Impact factor: 2.486

Review 8.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

9.  Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.

Authors:  Naroa Ibarretxe-Bilbao; Blanca Ramírez-Ruiz; Eduardo Tolosa; María Jose Martí; Francesc Valldeoriola; Nuria Bargalló; Carme Junqué
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

10.  Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI.

Authors:  Thomas Jubault; Simona M Brambati; Clotilde Degroot; Benoît Kullmann; Antonio P Strafella; Anne-Louise Lafontaine; Sylvain Chouinard; Oury Monchi
Journal:  PLoS One       Date:  2009-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.